Long-term evaluation of dabigatran 150 vs. 110 mg twice a day in patients with non-valvular atrial fibrillation

Michael D. Ezekowitz, John Eikelboom, Jonas Oldgren, Paul A. Reilly, Martina Brueckmann, Anthony P. Kent, Janice Pogue, Judith Spahr, Andreas Clemens, Herbert Noack, Hans-Christoph Diener, Lars Wallentin, Salim Yusuf, Stuart J. Connolly
  • EP Europace, March 2016, European Society of Cardiology
  • DOI: 10.1093/europace/euv312

The authors haven't yet claimed this publication.

Read Publication

http://dx.doi.org/10.1093/europace/euv312

In partnership with: